Failure of metformin and sulfonylurea combination therapy: should we stop or continue the use of sulfonylurea in combination with insulin glargine in type 2 diabetes patients in primary care?

Trial Profile

Failure of metformin and sulfonylurea combination therapy: should we stop or continue the use of sulfonylurea in combination with insulin glargine in type 2 diabetes patients in primary care?

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2012

At a glance

  • Drugs Insulin glargine; Metformin; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DIASULIN
  • Most Recent Events

    • 03 Jun 2012 Status changed from active, no longer recruiting to completed as reported by Netherlands Trials Register record..
    • 05 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top